Abstract
The relaxant activity of 2-( o, p-substituted phenyl)-1 H-benzimidazole derivatives with various 5- and 6-position substituents (–H, –CH 3, –NO 2, –CF 3), namely 1– 7, was recorded using the in vitro rat aorta ring test. Compounds 3 and 6 [2-(5-nitro-1 H-benzimidazol-2-yl)phenol and 2-(4-methoxyphenyl)-5-nitro-1 H-benzimidazole] were prepared using a short route, and were the most potent compounds of the series, showing IC 50 value of 0.95 and 1.41 (with endothelium) and 2.01 and 3.61 μM (without endothelium), respectively. Studying further structure–activity relationships through the use of bioisosteric substitution in these benzimidazole derivatives should provide novel vasorelaxant leads and possibly against hypertensive diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.